✦ LIBER ✦

Screening forBRCA1,BRCA2,CHEK2, PALB2,BRIP1,RAD50, andCDH1mutations in high-risk FinnishBRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals

✍ Scribed by Kirsi M Kuusisto; Aleksandra Bebel; Mauno Vihinen; Johanna Schleutker; Satu-Leena Sallinen

Book ID: 118726733
Publisher: BioMed Central
Year: 2011
Tongue: English
Weight: 549 KB
Volume: 13
Category: Article
ISSN: 1465-5411
DOI: 10.1186/bcr2832

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Spectrum of Mutations in BRCA1, BRCA2, C

Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer

✍ Walsh, T. 📂 Article 📅 2006 🏛 American Medical Association 🌐 English ⚖ 174 KB

Founder BRCA1 mutations and two novel ge

Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland

✍ Marco van der Looij; Barbara Wysocka; Izabela Brozek; Jacek Jassem; Janusz Limon 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 3 views

Germline mutations in the BRCA1 and BRCA2 genes account for the majority of high-risk breast/ovarian cancer families, depending on the population studied. Previously, BRCA1 mutations were described in women from Western Poland. To further characterize the spectrum of BRCA1 mutations and the impact o

Mutational analysis of the BRCA1-interac

Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals

✍ Joni L. Rutter; Amelia M. Smith; Michael R. Dávila; Alice J. Sigurdson; Ruthann 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

Two potential breast cancer susceptibility genes, encoding the BRCA1-interacting proteins ZNF350 (or ZBRK1) and BRIP1 (or BACH1), have been identified in yeast two-hybrid screens. We sequenced these genes in probands from 21 families with potentially inherited breast/ovarian cancer, all of which wer

BRCA1/2 mutation screening in high-risk

BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families

✍ Berzina, Dace; Nakazawa-Miklasevica, Miki; Zestkova, Jekaterina; Aksenoka, Karin 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 259 KB

Breast cancer risks in women with a fami

Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation

✍ Metcalfe, K A; Finch, A; Poll, A; Horsman, D; Kim-Sing, C; Scott, J; Royer, R; S 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 95 KB

BRCA1 5272-1G>A and BRCA2 5374delTATG ar

BRCA1 5272-1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin

✍ M Infante; M Durán; A Acedo; L Pérez-Cabornero; DJ Sanz; M García-González; E Be 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 554 KB